Can I skip my mammogram if I had a breast MRI this year?

No. The American Cancer Society says MRI can miss some cancers that a mammogram would find, so the two tests work as a pair. Women who qualify for MRI screening get both exams every year. Keep your mammogram on schedule even in a year when you also have an MRI.

Does a breast MRI use radiation?

No. MRI uses strong magnets and radio waves, not X-rays. The trade-off is an intravenous gadolinium contrast injection, a loud 30 to 60 minute exam in a narrow tube, and a higher false-positive rate than mammography.

How do I find out my lifetime breast cancer risk?

Ask your doctor to run a risk model that uses family history, such as the Tyrer-Cuzick (IBIS) model. The American College of Radiology recommends that every woman have a risk assessment by age 25. A result of 20% or higher meets the ACS threshold for yearly MRI plus mammogram.

Will insurance cover a screening breast MRI for dense breasts alone?

Often not without a fight. The USPSTF gave supplemental MRI for dense breasts an insufficient-evidence rating in 2024, so many plans treat it as optional. Coverage is more reliable when you meet a high-risk definition. Ask the imaging center for the cash price and whether prior authorization is required before you book.

What happens if the MRI finds something the mammogram did not?

The radiologist will usually recommend a targeted ultrasound, a follow-up MRI in six months, or an MRI-guided biopsy. In the first round of the DENSE trial, about 26% of MRI-prompted biopsies found cancer. The rest were benign. A finding on MRI is a reason for a closer look, not a diagnosis.

Should You Get a Breast MRI Instead of a Mammogram?

The short answer: For most women, no. Breast MRI is a supplement to mammography, not a replacement. The American Cancer Society states that if MRI is used, "it should be in addition to, not instead of, a screening mammogram," because MRI can miss some cancers that a mammogram finds. Yearly MRI plus mammogram is recommended for women at high risk: a lifetime risk of 20% or more, a BRCA1 or BRCA2 mutation, or chest radiation before age 30. For women with dense breasts and no other risk factor, MRI finds more cancers, but the 2024 USPSTF statement calls the evidence insufficient to recommend it.

Why is MRI not a replacement for a mammogram?

The two tests see different things. A mammogram is an X-ray that shows masses and tiny calcium deposits. An MRI uses magnets and an injected contrast dye to show blood flow into abnormal tissue. The American Cancer Society is direct: "MRI is not recommended as a screening test by itself because it can miss some cancers that a mammogram would find." MedlinePlus says the same: breast MRI "is not a replacement for mammography."

The second problem is specificity. Sensitivity is the share of real cancers a test catches. Specificity is the share of healthy women who get a clean result. MRI is more sensitive than mammography but less specific, so it flags more benign findings that need extra imaging or a biopsy. Our guide to mammogram accuracy covers the mammography side of that trade-off.

Who should get an MRI plus a mammogram every year?

The ACS guideline recommends a yearly breast MRI and a yearly mammogram, starting at age 30, for women who:

Have a lifetime risk of breast cancer of about 20% to 25% or greater, based on risk tools that rely mainly on family history.
Have a known BRCA1 or BRCA2 gene change.
Have a parent, sibling, or child with a BRCA1 or BRCA2 change and have not been tested themselves.
Had radiation therapy to the chest before age 30.
Have Li-Fraumeni, Cowden, or Bannayan-Riley-Ruvalcaba syndrome, or a first-degree relative with one of these.

The ACS says there is not enough evidence to recommend for or against yearly MRI for women with a 15% to 20% lifetime risk, or for women whose only risk factor is dense breasts. The American College of Radiology goes further. Its 2023 guideline calls for every woman to have a formal risk assessment by age 25, with particular attention to Black women and Ashkenazi Jewish women. It also recommends yearly supplemental MRI for women with a personal history of breast cancer and dense breasts.

What did the DENSE trial show in extremely dense breasts?

The strongest evidence for MRI in dense breasts comes from the Dutch DENSE trial, published in the New England Journal of Medicine in 2019. It randomized 40,373 women aged 50 to 75 with extremely dense breasts and a normal mammogram. One in five was invited to a supplemental MRI. The rest continued mammography alone. Over the next two years:

Interval cancers (cancers found between screens) were 2.5 per 1,000 in the MRI-invitation group versus 5.0 per 1,000 with mammography alone.
Among women who actually had the MRI, the interval cancer rate was 0.8 per 1,000.
MRI found 16.5 extra cancers per 1,000 screens. About 59% of invited women accepted the exam.
The false-positive rate was 79.8 per 1,000 screens. Only 17.4% of recalls and 26.3% of biopsies turned out to be cancer.

The second screening round looked better on the false-positive side. Among 3,436 women who returned for a second MRI, the cancer detection rate fell to 5.8 per 1,000. The false-positive rate fell to 26.3 per 1,000. One caution from the National Cancer Institute: no study has yet shown that MRI screening for dense breasts lowers breast cancer deaths.

Is an abbreviated MRI a faster option?

A standard breast MRI takes 30 to 45 minutes. An abbreviated MRI takes about 10 minutes. The EA1141 trial, published in JAMA in 2020, tested it head to head against 3D mammography (tomosynthesis). A total of 1,444 women with dense breasts, median age 54, had both exams at 48 sites in the United States and Germany. The results:

Abbreviated MRI found all 17 invasive cancers. Tomosynthesis found 7 of them.
Invasive cancer detection was 11.8 per 1,000 with abbreviated MRI versus 4.8 per 1,000 with tomosynthesis.
Sensitivity was 95.7% for MRI and 39.1% for tomosynthesis.
Specificity was 86.7% for MRI and 97.4% for tomosynthesis. The share of biopsies that found cancer was 19.6% with MRI and 31.0% with tomosynthesis.

The short protocol keeps the detection advantage of full MRI and shares its false-positive cost. The ACR Appropriateness Criteria 2024 update lists MRI and abbreviated MRI as usually appropriate for high-risk women at any density, and for intermediate-risk women with dense breasts. For average-risk women with dense breasts, it lists contrast-enhanced mammography, ultrasound, MRI, and abbreviated MRI as options that may help. For what the scanner experience involves, mri.md covers MRI exams in detail.

What do the USPSTF and FDA say about dense breasts?

The 2024 USPSTF recommendation gives mammography every two years from age 40 to 74 a Grade B. On supplemental imaging it issued an "I" statement: "the current evidence is insufficient to assess the balance of benefits and harms of supplemental screening for breast cancer using breast ultrasonography or magnetic resonance imaging (MRI) in women identified to have dense breasts on an otherwise negative screening mammogram." An "I" statement is not a recommendation against MRI. It means the task force wants outcome data it does not yet have.

The FDA breast density rule, in force since September 2024, requires every facility to send each patient a written density summary. If your tissue is dense, the letter must say: "Dense tissue makes it harder to find breast cancer on a mammogram and also raises the risk of developing breast cancer. Your breast tissue is dense." It must also state that "in some people with dense tissue, other imaging tests in addition to a mammogram may help find cancers." The rule states the fact. It does not tell you what to do with it. Our guide to dense breasts explains the four categories. The DENSE trial studied only the top one, extremely dense.

What are the costs and downsides of a breast MRI?

Cost. The ACS notes that breast MRI "can cost a lot" and often needs insurance approval before the scan. Coverage for dense breasts alone varies by plan and by state law. Ask for the price and the prior-authorization status before you schedule.

Contrast. Screening MRI requires a gadolinium-based contrast agent injected through an IV. MedlinePlus reports that allergic reactions are rare, and that the dye can be harmful to people with kidney problems who need dialysis. The FDA label for gadobutrol (Gadavist), one agent approved for breast MRI, states that gadolinium "is retained for months or years in several organs," with the highest levels in bone, followed by brain and skin. The label reports rare skin changes in people with normal kidney function and advises clinicians to "minimize repetitive GBCA imaging studies, particularly closely spaced studies, when possible." A woman who starts yearly MRI at 30 faces decades of injections, which is worth a conversation with her doctor.

The exam. You lie face down on a narrow table with your breasts in cushioned openings. The machine is loud, and the test usually lasts 30 to 60 minutes. Pacemakers and some metal implants rule it out.

False positives. Roughly 8% of women in the first DENSE round were called back for a benign finding. If that happens to you, our callback guide explains the next steps.

The bottom line

Do not swap your mammogram for an MRI. Add an MRI to it if you qualify. Women with a 20% or greater lifetime risk, a BRCA mutation, or chest radiation before 30 should have both exams every year, starting at 30. Women with extremely dense breasts and no other risk factor sit in a gray zone: the DENSE trial shows MRI halves interval cancers, while the USPSTF and ACS say the evidence is not yet strong enough for a blanket recommendation. Get a risk assessment, read the density line in your mammogram letter, and decide with your doctor. If you choose MRI, expect a contrast injection, a real chance of a benign callback, and a bill to check first.

Last updated: September 2026. This article is for informational purposes only and does not constitute medical advice. Talk with your doctor or radiologist about your lifetime risk, your breast density, and whether supplemental MRI is right for you.